Legal & General Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Legal & General Group’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,535	Closed	-$4.99K	–	3584
2023 Q1	$4.99K	Sell	11,535 -18,838	-62%	-$14.5K	﹤0.01%	3302
2022 Q4	$35.8K	Buy	30,373 +9,516	+46%	+$15.5K	﹤0.01%	3004
2022 Q3	$49K	Buy	20,857 +5,739	+38%	+$15K	﹤0.01%	2981
2022 Q2	$33K	Buy	+15,118	New	+$105K	﹤0.01%	3094

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Legal & General Group's GRNA Position: Q2 2023 in Review

Legal & General Group sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 11,535 shares — an estimated $4.99K sold.

Legal & General Group first reported a position in GRNA in Q2 2022 and held it in 4 quarters. The position peaked at $49K in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

Legal & General Group reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
Legal & General Group sold 11,535 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $4.99K.
Legal & General Group first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 4 quarters.
Legal & General Group's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $49K in Q3 2022.
48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.